Ionis Pharmaceuticals Inc.

IONS | NASDAQ

Price Alert Chart Builder DCF Calculator

$45.47

+$0.57 (+1.27%)

Sep 22, 2026, 2:01 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Upgrade now ➞

Related Stocks

Company	Yield
ASND Ascendis Pharma A/S	N/A
BBIO BridgeBio Pharma	N/A
BMRN BioMarin Pharmaceutical	N/A
EXEL Exelixis	N/A
GH Guardant Health	N/A
MDGL Madrigal Pharmaceuticals	N/A
MRNA Moderna	N/A
ROIV Roivant Sciences	N/A
RVMD Revolution Medicines	N/A
SMMT Summit Therapeutics	N/A

Dividend Rankings ➞

Recent News

2 days ago / fool.com
Investors Dumped Ionis Pharmaceuticals Stock -- But Wall Street Hasn't Budged From Its Bullish Outlook
3 days ago / marketbeat.com
Ionis Pharmaceuticals Eyes TRYNGOLZA Growth as Pipeline Faces Cardio Setbacks
6 days ago / seekingalpha.com
Ionis Pharmaceuticals, Inc. (IONS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
12 days ago / seekingalpha.com
Ionis Pharmaceuticals, Inc. (IONS) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
13 days ago / fool.com
Cathie Wood Is Loading Up on Ionis Pharmaceuticals (IONS) Stock. Here's the Bet She's Making.
14 days ago / defenseworld.net
Ionis Pharmaceuticals (NASDAQ:IONS) Shares Gap Down After Analyst Downgrade
18 days ago / seekingalpha.com
Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval and Launch Strategy for ZANVASTRO in Alexander Disease Transcript
18 days ago / marketbeat.com
Ionis Pharmaceuticals Wins FDA Approval for First Alexander Disease Treatment
18 days ago / zacks.com
IONS Secures FDA Nod for Rare Brain Disorder Drug Zanvastro
19 days ago / gurufocus.com
ZANVASTRO™ (zilganersen) approved by the FDA as the first and only disease modifying treatment for Alexander disease (AxD) in pediatric and adult patients